Dr. Reddy's Laboratories is recalling approximately 33,958 bottles of Divalproex Sodium (the generic equivalent of Depakote ER) 250 mg tablets because the medication was exposed to humidity levels above 50% during the packaging process. This manufacturing defect could potentially affect the stability and effectiveness of the medication. The recall includes 100-count and 500-count bottles that were distributed to major retailers and pharmacies nationwide. If you use this medication to treat seizures or mood disorders, contact your healthcare provider or pharmacist immediately to discuss a replacement, as stopping this medication suddenly can be dangerous.
Exposure to excessive humidity during packaging can degrade the chemical stability of extended-release tablets. This may result in the medication not being released into the body at the correct rate, potentially leading to sub-therapeutic levels of the drug and a loss of symptom control.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.